Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate of less than 8%, and is predicted to become the second leading cause of cancer-related death by 2030. Alongside late detection, which impacts upon surgical treatment, PDAC tumours are challenging to treat due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Edward P., Coetzee, Abigail S., Tomas Bort, Elena, Wang, Qiaoying, Kocher, Hemant M., Grose, Richard P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068358/
https://www.ncbi.nlm.nih.gov/pubmed/33918004
http://dx.doi.org/10.3390/cells10040847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068358/
https://www.ncbi.nlm.nih.gov/pubmed/33918004
http://dx.doi.org/10.3390/cells10040847

Ejemplares similares